Le Lézard
Classified in: Health
Subjects: AWD, TDS, PET

[CES 2023] AI FOR PET NAMED AS CES 2023 INNOVATION AWARDS HONOREE


SEOUL, South Korea, Nov. 16, 2022 /PRNewswire/ -- AI FOR PET today announced that it has been named as CES 2023 Innovation Awards Honoree for TTcare. This year's CES Innovation Awards program received a record-high number of over 2100 submissions. The announcement was made ahead of CES 2023, the world's most influential technology event, happening Jan. 5-8 in Las Vegas, NV.

[CES 2023] AI FOR PET NAMED AS CES 2023 INNOVATION AWARDS HONOREE

The CES Innovation Awards program, owned and produced by the Consumer Technology Association (CTA), is an annual competition honoring outstanding design and engineering in 28 consumer technology product categories. An elite panel of industry expert judges, including members of the media, designers, engineers, and more, reviewed submissions based on innovation, engineering, functionality, aesthetics, and design.

TTcare is a healthcare app for pets that detects signs of diseases and health issues. After taking a photo of your dog or cat, TTcare's AI software analyzes the image and informs the user of potential eye, skin, or joint-related diseases and conditions. These preventative measures allow quicker treatment to increase pets' lifespan and quality of life.

TTcare's technology for eye and skin health checks using mobile phone photos has been patented in Korea, and three PCT patents are pending. Its' technology has also been validated by being approved by the Korean government for "AI-based medical device software for animals" and by being honored for the CES 2022 and 2023 Innovation Awards.

CEO Euna Huh said, "Being named a CES Innovation Award Honoree for two years in a row shows that AI FOR PET has not stayed in place for the past year but has taken a couple of steps further. AI FOR PET will continue to try to develop services for companion animals and their parents."

AI FOR PET launched TTcare in June 2022 in the U.S., with plans to launch joint check capabilities for dogs in December 2022.

SOURCE AI FOR PET


These press releases may also interest you

at 02:25
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders is pleased to announce a new partnership with Al Shirawi Healthcare solutions, a leading distributor of medical technologies...

at 02:20
BioInvent International (STO:BINV)"During the first quarter of the year, we continued making excellent progress with our clinical pipeline targeting TNFR2 and FcyRIIB, building on the momentum we generated during a very successful 2023. Looking...

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...



News published on and distributed by: